14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.670 $1.31 Friday, 3rd May 2024 VIRX stock ended at $0.81. This is 3.55% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.00% from a day low at $0.80 to a day high of $0.84.
90 days $0.540 $1.31
52 weeks $0.430 $2.38

Historical Viracta Therapeutics, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $0.84 $0.84 $0.80 $0.81 32 999
May 02, 2024 $0.82 $0.85 $0.81 $0.84 60 477
May 01, 2024 $0.82 $0.88 $0.80 $0.82 19 266
Apr 30, 2024 $0.85 $0.90 $0.81 $0.82 39 924
Apr 29, 2024 $0.81 $0.86 $0.81 $0.82 84 298
Apr 26, 2024 $0.85 $0.85 $0.82 $0.83 35 904
Apr 25, 2024 $0.85 $0.86 $0.82 $0.85 37 784
Apr 24, 2024 $0.87 $0.90 $0.83 $0.84 55 032
Apr 23, 2024 $0.91 $0.91 $0.760 $0.85 83 532
Apr 22, 2024 $0.85 $0.90 $0.84 $0.88 12 335
Apr 19, 2024 $0.88 $0.91 $0.82 $0.86 52 537
Apr 18, 2024 $0.91 $0.99 $0.85 $0.91 79 314
Apr 17, 2024 $0.737 $0.95 $0.737 $0.94 190 538
Apr 16, 2024 $0.773 $0.82 $0.670 $0.715 255 333
Apr 15, 2024 $1.03 $1.04 $0.760 $0.780 603 802
Apr 12, 2024 $1.30 $1.31 $1.08 $1.15 327 826
Apr 11, 2024 $1.15 $1.31 $1.10 $1.17 347 186
Apr 10, 2024 $1.08 $1.14 $1.03 $1.14 71 772
Apr 09, 2024 $1.09 $1.11 $1.02 $1.06 76 417
Apr 08, 2024 $1.09 $1.10 $1.03 $1.07 143 137
Apr 05, 2024 $1.08 $1.08 $0.99 $1.02 65 586
Apr 04, 2024 $1.09 $1.11 $1.01 $1.04 75 662
Apr 03, 2024 $1.06 $1.09 $1.05 $1.09 71 481
Apr 02, 2024 $1.11 $1.12 $1.05 $1.09 111 126
Apr 01, 2024 $1.05 $1.14 $1.04 $1.11 248 020
Click to get the best stock tips daily for free!

About Viracta Therapeutics, Inc.

Viracta Therapeutics. Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as we... VIRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT